Replies to post #96831 on Biotech Values

[DewDiligence]

Grifols’ shareholders do not like the TLCR deal, evidently. The shares closed down 9% in Madrid, hitting a 3.5-year low:

http://ifbasp.infobolsanet.com/IFBLayout/Layout.aspx?layout=FichaValorGrafico&numsolapa=3&client=grifols08&stock=M_GRF&lang=en

[turtlepower]

Perhaps this is a way to make up for any revenue loss due to pricing pressure in the EU.